Your Catalyst To a Lucrative Business
Factors that propel this segment are high incidence of diabetes and the growing necessity for glucose analysis on a regular basis .
The OTC & rapid diagnostic tests market may expand robustly over the forecast period because of the “ s elf diagnosis ” trend . People nowadays are highly aware of the importance of early disease diagnosis for on -time & instant disease treatment . Based on end users , the global industry is divided into laboratories , hospitals , clinics , assisted living healthcare facilities , homes , and others . Hospitals & clinics generate highest revenues in the overall market . Diagnostic tests are mostly conducted in clinics and in hospitals . As a result , most of these healthcare centers have begun expanding their POC diagnostic facilities .
Geographically , the worldwide Point Of Care Diagnostics Market is categorized into Asia Pacific , Europe , North America , and Rest of the World ( RoW ). North America is the largest regional industry . High degree of patient awareness , encouraging government initiatives , and substantial investments in medical infrastructure are prominent regional drivers . It is however , expected that Asia Pacific will register the highest growth rate over the forecast period . This attributes to improvements in healthcare infrastructure in emerging countries , such as India and China .
Companies operating in the global Point Of Care Diagnostics Market continuously strive towards capturing higher market shares . They invest robustly in R & D and product innovations . Prominent market competitors are Trinity Biotech PLC , Danaher Corporation , Siemens Healthcare , Roche Diagnostics , and Becton Dickinson and Company .
In September 2016 , Novartis launched the Niji TM System and Total IgE Test , a POC diagnostic tool . By using just a droplet or two of finer stick blood , this device delivers Immunoglobulin E ( IgE ) levels in a matter of twelve minutes . This test caters to immediate in-office diagnosis of allergies associated with IgE levels . The availability of such tests in the offices of healthcare providers leads to reduced time for consultation , diagnosis , prognosis , and disease treatment . This in turn leads to better patient outcomes .
Browse Related Category Market Reports @ https :// www . hexaresearch . com / research-category / clinicaldiagnostics-industry
Follow Us :